查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1433599

美国医疗设备製造商市场规模、份额、趋势分析报告：按应用和细分市场预测，2024-2030

U.S. Medical Device Manufacturers Market Size, Share & Trends Analysis Report By Application (Orthopedic, Cardiovascular, Neurology, Drug Delivery, Ophthalmic, Nephrology and Urology Devices) And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 137 Pages | 商品交期: 2-10个工作天内

价格

美国医疗设备製造商市场成长与趋势：

Grand View Research, Inc.最新报告显示，到2030年，美国医疗设备製造商市场规模预计将达到3,601亿美元，复合年增长率为5.8%。

该区域市场主要是由该国高额医疗保健支出推动的。预计老年人口的增加和慢性病盛行率的上升也将促进预测期内的市场成长。

COVID-19 大流行引发了对手套、注射器、口罩、个人防护装备、红外线套件、脉搏体温计脉动式血氧监测仪系统和检测套组等医疗消耗品和病患辅助用具辅助用品的需求急剧增加。这为现有参与者和新进入者创造了巨大的商机。然而，疫情也导致减重手术、关节重建手术和整容手术等择期手术大幅减少，限制了上述手术中使用的医疗设备的成长。从2021年中期开始，由于政府积极努力重启择期手术，市场预计将復苏。

在美国，医疗设备研发投入不断加大，尖端技术采用率较高，为医疗设备製造商创造了理想的商业环境。该国越来越多地采用微创手术也推动了市场的发展。此外，由于意外事故以及久坐生活方式引起的疾病而导致的病例增加，将推动预测期内的市场成长。

美国有优惠的报销政策，例如美国的医疗保险制度。波士顿科学公司 (Boston Scientific Corp.) 与医疗保险和医疗补助服务 (CMS) 合作，为属于流动支付分类 (APC) 的 C 代码涵盖的所有设备提供报销。儘管这种有利的报销结构预计将促进市场成长，但法规不断变化的性质可能会受到突然修订的影响，这可能会对市场产生重大影响。

美国医疗设备製造商市场报告亮点

  • 到2023年，给药装置将占据压倒性的市场占有率，达到28.2%。影响估计份额的因素包括患者便利性和依从性、慢性病盛行率上升、改善疾病管理的技术进步以及老年人口的不断增长。
  • 2023 年 3 月，美国大学科学家团队开发了一种新的药物传递技术，有望帮助对抗鸦片类药物流行、改善癌症治疗和改善復健医学。
  • 行业领导者不断增加的策略性倡议也推动了市场成长
  • 2023年，美敦力和DaVita Inc.宣布成立Mozarc Medical。该公司的目标是为肾臟健康创造解决方案。
  • 此外，2023年，GE医疗与生物医学高级研究与开发局签署了价值4,400万美元的合约。根据协议，GE 将提供诊断和影像解决方案来治疗创伤。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章美国医疗设备製造商市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 美国医疗设备製造商的市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章美国医疗设备製造商市场：应用预估与趋势分析

  • 2023年及2030年应用市场占有率
  • 细分仪表板
  • 美国医疗设备製造商按应用市场前景

第五章竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
  • 供应商形势
    • Key company market share analysis, 2023
    • Stryker
    • Cardinal Health
    • Eli Lily and Company
    • Intuitive Surgical
    • Edwards Lifesciences Corporation
    • BD
    • Danaher
    • 3M
    • Abbott
    • Baxter
    • B. Braun SE
    • GE HealthCare
    • Johnson &Johnson Services, Inc.
    • Medtronic
    • Boston Scientific Corporation
Product Code: GVR-3-68038-032-3

U.S. Medical Device Manufacturers Market Growth & Trends:

The U.S. medical device manufacturers market size is expected to reach USD 360.1 billion by 2030 and is projected to expand at a CAGR of 5.8%, according to a new report by Grand View Research, Inc. The regional market is significantly driven by the high healthcare expenditure of the country. The increasing geriatric population coupled with the rising prevalence of chronic diseases is also expected to augment the market growth over the forecast period.

The COVID-19 pandemic triggered a drastic rise in demand for medical consumables and patient aids, such as gloves, syringes, masks, PPE kits, infrared thermometers, pulse oximeter, testing kits, etc. This resulted in an immense opportunity for the existing players as well as new entrants. However, the pandemic also resulted in a massive reduction in elective procedures, such as bariatric surgeries, joint replacement surgeries, cosmetic surgeries, etc., thus restricting the growth of medical devices used in the aforementioned procedures. The market recovery can be expected from mid-2021 onwards with favorable government initiatives to re-launch elective procedures.

Growing investments in medical device R&D along with the high adoption rate of advanced technology in the U.S., create the perfect business environment for medical device manufacturers in the country, providing them with lucrative opportunities to accelerate their business operations. Increasing adoption of minimally invasive surgeries in the country is also driving the market. In addition, rising cases of accidental injuries coupled with diseases caused due to sedentary lifestyle will propel the market growth over the forecast period.

The U.S. has favorable reimbursement policies such as the U.S. Medicare system. Boston Scientific Corp., in association with the Centers for Medicare and Medicaid Services (CMS), offers reimbursement for all devices that fall under Ambulatory Payment Classifications (APCs), covered under C-codes. These favorable reimbursement structures are expected to fuel market growth; however, the ever-evolving nature of regulations may lead to abrupt amends, which may significantly impact the market.

U.S. Medical Device Manufacturers Market Report Highlights:

  • Drug delivery devices held a dominant market share of 28.2% in 2023. Factors responsible for the estimated share include patient convenience and compliance, rising prevalence of chronic diseases, technological advancements to improve disease management, and increasing geriatric population.
  • In March 2023, a team of scientists at Northwestern University, U.S., developed a novel drug-delivery technology that is expected to have implications for the opioid epidemic and cancer treatment and to improve rehabilitation care.
  • The growing strategic initiative by industry leaders is also driving market growth
  • In 2023, Medtronic and DaVita Inc. announced the launch of a new company, Mozarc Medical. The company aims to create solutions for kidney health.
  • Furthermore, in 2023, GE HealthCare signed a USD 44 million contract with the Biomedical Advanced Research and Development Authority. Within this contract, GE is expected to provide diagnostic and imaging solutions to treat traumatic injuries.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Application
    • 1.2.2. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in U.S.
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Application outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Medical Device Manufacturers Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Growing geriatric population
      • 3.2.1.2. High adoption of minimally invasive procedures
      • 3.2.1.3. Increase in the number of sports and road accidents
      • 3.2.1.4. Increasing geographic reach of market players
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Increase in the number of product recalls
      • 3.2.2.2. Social and ethical issues
      • 3.2.2.3. Slow approval procedures
  • 3.3. U.S. Medical Device Manufacturers Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. U.S. Medical Device Manufacturers Market: Application Estimates & Trend Analysis

  • 4.1. Application Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. U.S. Medical Device Manufacturers Market by Application Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Orthopedic Devices
      • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.4.2. Cardiovascular Devices
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.4.3. Neurology Devices
      • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.4.4. Drug Delivery Devices
      • 4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.4.5. Ophthalmic Devices
      • 4.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.4.6. Nephrology and Urology Devices
      • 4.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
    • 4.4.7. Others
      • 4.4.7.1. Market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 5. Competitive Landscape

  • 5.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 5.2. Company/Competition Categorization
  • 5.3. Vendor Landscape
    • 5.3.1. Key company market share analysis, 2023
    • 5.3.2. Stryker
      • 5.3.2.1. Company overview
      • 5.3.2.2. Financial performance
      • 5.3.2.3. Product benchmarking
      • 5.3.2.4. Strategic initiatives
    • 5.3.3. Cardinal Health
      • 5.3.3.1. Company overview
      • 5.3.3.2. Financial performance
      • 5.3.3.3. Product benchmarking
      • 5.3.3.4. Strategic initiatives
    • 5.3.4. Eli Lily and Company
      • 5.3.4.1. Company overview
      • 5.3.4.2. Financial performance
      • 5.3.4.3. Product benchmarking
      • 5.3.4.4. Strategic initiatives
    • 5.3.5. Intuitive Surgical
      • 5.3.5.1. Company overview
      • 5.3.5.2. Financial performance
      • 5.3.5.3. Product benchmarking
      • 5.3.5.4. Strategic initiatives
    • 5.3.6. Edwards Lifesciences Corporation
      • 5.3.6.1. Company overview
      • 5.3.6.2. Financial performance
      • 5.3.6.3. Product benchmarking
      • 5.3.6.4. Strategic initiatives
    • 5.3.7. BD
      • 5.3.7.1. Company overview
      • 5.3.7.2. Financial performance
      • 5.3.7.3. Product benchmarking
      • 5.3.7.4. Strategic initiatives
    • 5.3.8. Danaher
      • 5.3.8.1. Company overview
      • 5.3.8.2. Financial performance
      • 5.3.8.3. Product benchmarking
      • 5.3.8.4. Strategic initiatives
    • 5.3.9. 3M
      • 5.3.9.1. Company overview
      • 5.3.9.2. Financial performance
      • 5.3.9.3. Product benchmarking
      • 5.3.9.4. Strategic initiatives
    • 5.3.10. Abbott
      • 5.3.10.1. Company overview
      • 5.3.10.2. Financial performance
      • 5.3.10.3. Product benchmarking
      • 5.3.10.4. Strategic initiatives
    • 5.3.11. Baxter
      • 5.3.11.1. Company overview
      • 5.3.11.2. Financial performance
      • 5.3.11.3. Product benchmarking
      • 5.3.11.4. Strategic initiatives
    • 5.3.12. B. Braun SE
      • 5.3.12.1. Company overview
      • 5.3.12.2. Financial performance
      • 5.3.12.3. Product benchmarking
      • 5.3.12.4. Strategic initiatives
    • 5.3.13. GE HealthCare
      • 5.3.13.1. Company overview
      • 5.3.13.2. Financial performance
      • 5.3.13.3. Product benchmarking
      • 5.3.13.4. Strategic initiatives
    • 5.3.14. Johnson & Johnson Services, Inc.
      • 5.3.14.1. Company overview
      • 5.3.14.2. Financial performance
      • 5.3.14.3. Product benchmarking
      • 5.3.14.4. Strategic initiatives
    • 5.3.15. Medtronic
      • 5.3.15.1. Company overview
      • 5.3.15.2. Financial performance
      • 5.3.15.3. Product benchmarking
      • 5.3.15.4. Strategic initiatives
    • 5.3.16. Boston Scientific Corporation
      • 5.3.16.1. Company overview
      • 5.3.16.2. Financial performance
      • 5.3.16.3. Product benchmarking
      • 5.3.16.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 U.S. Medical Device Manufacturers market revenue estimates and forecast, by application, 2018 - 2030 (USD Billion)
  • Table 4 Key companies undergoing acquisitions/expansions
  • Table 5 Key companies undergoing product launch/approval
  • Table 6 Key companies undergoing partnership & collaboration

List of Figures

  • Fig. 1 U.S. Medical Device Manufacturers market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market formulation & validation
  • Fig. 7 Market snapshot
  • Fig. 8 Competitive landscape
  • Fig. 9 Market Dynamics
  • Fig. 10 U.S. Medical Device Manufacturers market: PORTER's analysis
  • Fig. 11 U.S. Medical Device Manufacturers market: PESTEL analysis
  • Fig. 12 U.S. Medical Device Manufacturers market: by application: key takeaways
  • Fig. 13 U.S. Medical Device Manufacturers market, by application: market share, 2023 & 2030
  • Fig. 14 Orthopedic devices market, 2018 - 2030 (USD Billion)
  • Fig. 15 Cardiovascular devices market, 2018 - 2030 (USD Billion)
  • Fig. 16 Neurology devices market, 2018 - 2030 (USD Billion)
  • Fig. 17 Drug delivery devices market, 2018 - 2030 (USD Billion)
  • Fig. 18 Ophthalmic devices market, 2018 - 2030 (USD Billion)
  • Fig. 19 Nephrology and urology devices market, 2018 - 2030 (USD Billion)
  • Fig. 20 Others market, 2018 - 2030 (USD Billion)
  • Fig. 21 Key company categorization
  • Fig. 22 Heat map analysis
  • Fig. 23 U.S orthopedic devices market share analysis, 2023
  • Fig. 24 U.S cardiac care devices market share analysis, 2023
  • Fig. 25 U.S drug delivery devices market share analysis, 2023
  • Fig. 26 Strategic framework